je.st
news
Tag: license agreement
Samsung, Nokia extend patent license agreement
2013-11-04 09:28:00| Telecompaper Headlines
(Telecompaper) Samsung has extended a patent license agreement between Nokia and Samsung for five years. The agreement would have expired at the end of 2013. Under the terms of the extended agreement, Samsung will pay additional compensation to Nokia for the period commencing from 1 January 2014 onwards, and the amount of such compensation shall be finally settled in a binding arbitration which is expected to be concluded during 2015.
Tags: agreement
license
samsung
nokia
Acacia Subsidiary Enters into Settlement and Patent License Agreement with Zayo Group, LLC
2013-10-28 14:07:15| Semiconductors - Topix.net
Founded in 1993, Acacia Research Corporation is the industry leader in patent licensing.
Tags: group
agreement
license
llc
Acacia Subsidiary Enters into Settlement and Patent License Agreement with Rockyou, Inc.
2013-10-26 08:57:44| Semiconductors - Topix.net
Acacia Research Corporation announced today that its GameTek LLC subsidiary has entered into a patent license and settlement agreement with Rockyou, Inc. This agreement resolves patent litigation that was pending in the United States District Court for the Northern District of California.
Tags: inc
agreement
license
patent
BASF and Sabo Enter into License Agreement for light Stabilizer Chimassorb 2020
2013-10-02 07:00:00| Coatings World Breaking News
Tags: enter
light
agreement
license
Merck and AstraZeneca Enter License Agreement for Investigational Oral WEE1 Kinase Inhibitor Therapy for Cancer
2013-09-11 09:15:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. & LONDON WHITEHOUSE STATION, N.J. & LONDON--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and AstraZeneca (NYSE: AZN) today announced a worldwide licensing agreement for Mercks oral small molecule inhibitor of WEE1 kinase (MK-1775). MK-1775 is currently being evaluated in Phase IIa clinical studies in combination with standard-of-care therapies for the treatment of patients with certain types of ovarian cancer. Language: English Contact: MerckMedia:Caroline Lappetito, (267) 305-7639orInvestor:Carol Ferguson, (908) 423-4465Justin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: for
enter
agreement
license
Sites : [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] next »